The generation of common subsets with varying parameters made it possible to analyse complete panels of compounds across variants. The versatility of such analysis on different protein families was exemplified for targets previously highlighted based on bioactivity data density and variant bioactivity percentage, namely EGFR (Figure , Supplementary Figures ), HIV-1 RNaseH-RT, IDHC, and bromodomain-containing protein BRD4 -O60885